Comment Resolutions: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 121: | Line 121: | ||
| Clinically Feasible | | Clinically Feasible | ||
| 2023.02.07 | | 2023.02.07 | ||
| [[Media:QIBA US SWS Comments 2023-02-20.xlsx| Clinically Feasible Comment Resolutions 2023-02-20]] | | [[Media:QIBA US SWS Comments 2023-02-20-v2.xlsx| Clinically Feasible Comment Resolutions 2023-02-20]] | ||
|- | |- | ||
|} | |} | ||
Revision as of 20:27, 9 March 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.